國藝娛樂(08228.HK)就發行新股未接獲判決書
國藝娛樂(08228.HK)公布,因近期冠狀病毒爆發及公眾健康考慮,香港法院自1月29日起關閉,所有於香港法院/審裁處的聆訊均已押後進行,日期待定。
公司並未接獲香港法院的判決書,而計劃亦未獲正式批准。公司其後知會認購人,而雙方互相同意,儘管雙方已妥為簽立日期為2月4日的認購事項協議,該協議於最初已屬無效。於2月5日的交易時段後,公司立即刊發澄清公告,表明於該公告該公告日期,概無達成有關認購股份及避免公司證券出現虛假市場的任何正式協議。
法院原訂1月31日就公司計劃安排計劃及根據一般授權認購公司新股份頒布裁決。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.